These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12562310)

  • 1. Vaginal ring delivery of hormone replacement therapy--a review.
    Dezarnaulds G; Fraser IS
    Expert Opin Pharmacother; 2003 Feb; 4(2):201-12. PubMed ID: 12562310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of 17-beta-oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation.
    Schmidt G; Andersson SB; Nordle O; Johansson CJ; Gunnarsson PO
    Gynecol Obstet Invest; 1994; 38(4):253-60. PubMed ID: 7851811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women.
    Noé G; Sitruk-Ware R; Zegers-Hochschild F; Variano B; Montero JC; Arriagada P; Li A; Stanczyk FZ; Felix JC; Mishell DR; Croxatto HB
    Climacteric; 2010 Oct; 13(5):433-41. PubMed ID: 20642326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal rings for menopausal symptom relief.
    Ballagh SA
    Drugs Aging; 2004; 21(12):757-66. PubMed ID: 15382956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol/progesterone-releasing vaginal rings for hormone replacement therapy in postmenopausal women.
    Hamada AL; Maruo T; Samoto T; Yoshida S; Nash H; Spitz IM; Johansson E
    Gynecol Endocrinol; 2003 Jun; 17(3):247-54. PubMed ID: 12857433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review.
    Sarkar NN
    Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):217-24. PubMed ID: 15006269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17 beta and progesterone in postmenopausal women.
    Pschera H; Hjerpe A; Carlström K
    Gynecol Obstet Invest; 1989; 27(4):204-7. PubMed ID: 2744624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol delivery by vaginal rings: potential for hormone replacement therapy.
    Nash HA; Brache V; Alvarez-Sanchez F; Jackanicz TM; Harmon TM
    Maturitas; 1997 Jan; 26(1):27-33. PubMed ID: 9032744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
    Baker VL
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns.
    Di Carlo C; Tommaselli GA; Gargano V; Savoia F; Bifulco G; Nappi C
    Climacteric; 2010 Oct; 13(5):442-6. PubMed ID: 20575654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group.
    Casper F; Petri E
    Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(3):171-6. PubMed ID: 10430010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.
    Ayton RA; Darling GM; Murkies AL; Farrell EA; Weisberg E; Selinus I; Fraser ID
    Br J Obstet Gynaecol; 1996 Apr; 103(4):351-8. PubMed ID: 8605133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data review.
    Simon JA; Archer DF; Constantine GD; Pickar JH; Amadio JM; Bernick B; Graham S; Mirkin S
    Maturitas; 2017 May; 99():51-58. PubMed ID: 28364869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estradiol vaginal ring--a study of existing clinical data.
    Bachmann G
    Maturitas; 1995 Dec; 22 Suppl():S21-9. PubMed ID: 8775773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
    Lynch C
    J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.